TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT02702115

Ascending Dose Study of Genome Editing by the Zinc Finger Nuclease (ZFN) Therapeutic SB-318 in Subjects With MPS I

Cause of deathOther Automatic label, confidence 0.5, unverified. How labels are made.
“All three subjects dosed in the study have rolled over to the Long-Term Follow-up Study IVPRP-LT01 (NCT04628871)”

The sponsor’s own words in the registry.

Life of this trial

201620172018201920202021202220232024Registered2016-02-29Started2017-05-24Stopped2021-11-03Results posted2023-01-26

Vital statistics

Status
Terminated
Phase
Phase 1, Phase 2
Sponsor
Sangamo Therapeutics
Sponsor type
Industry
Conditions
MPS I
Interventions
SB-318
Participants
3
Sites
1
Countries
United States

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.